Evidence map›Paper›PMID 37728652›Full record

ArticleWiener klinische Wochenschrift2023

[Diagnostic and therapy of lupus nephritis - 2023].

Balazs Odler, Marion J Pollheimer, Andreas Kronbichler, Marcus D Säemann, Martin Windpessl, Philipp Gauckler, Michael Rudnicki, Emanuel Zitt, Irmgard Neumann, Karl Lhotta and 1 more

Abstract readEnglish Abstract
In one paragraph

Article in Wiener klinische Wochenschrift, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Balazs OdlerAbteilung für Nephrologie, Innere Medizin, Medizinische Universität Graz, Graz, Österreich.
Marion J PollheimerInstitut für Pathologie, Medizinische Universität Graz, Graz, Österreich.
Andreas KronbichlerDepartment Innere Medizin 4 (Nephrologie und Hypertensiologie), Medizinische Universität Innsbruck, Innsbruck, Österreich.
Marcus D Säemann6. Medizinische Abteilung mit Nephrologie & Dialyse, Klinik Ottakring, Wien, Österreich.
Martin WindpesslAbteilung für Innere Medizin IV, Klinikum Wels-Grieskirchen, Wels, Österreich.
Philipp GaucklerDepartment Innere Medizin 4 (Nephrologie und Hypertensiologie), Medizinische Universität Innsbruck, Innsbruck, Österreich.
Michael RudnickiDepartment Innere Medizin 4 (Nephrologie und Hypertensiologie), Medizinische Universität Innsbruck, Innsbruck, Österreich.
Emanuel ZittAbteilung für Innere Medizin III (Nephrologie, Dialyse und Hypertensiologie), Akademisches Lehrkrankenhaus Feldkirch, Feldkirch, Österreich.
Irmgard NeumannVasculitis.at, Wien, Österreich.
Karl LhottaAbteilung für Innere Medizin III (Nephrologie, Dialyse und Hypertensiologie), Akademisches Lehrkrankenhaus Feldkirch, Feldkirch, Österreich.
Kathrin EllerAbteilung für Nephrologie, Innere Medizin, Medizinische Universität Graz, Graz, Österreich. kathrin.eller@medunigraz.at.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The manuscript summarizes the consensus of the Austrian Society of Nephrology on the diagnosis and therapy of lupusnephritis, which is built on existing studies and literature. We discuss in detail the immunosuppressive treatment in proliferative forms of lupusnephritis (III and IV ± V) and in pure lupusnephritis V with nephrotic-range proteinuria. Furthermore, the supportive medication in lupusnephritis is summarized in the consensus. The figures were designed to provide the reader a guidance through the therapeutical approach in lupusnephritis for the daily practice.

Indexed as

Lupus NephritisNephrologyAustriaConsensusHumansImmunosuppressionProliferative lupus nephritisProteinuriaSupportive therapy

Identifiers

PMID37728652
PMCPMC10511585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.